SG11201605259QA - Methods for measuring biomarkers in gastrointestinal cancer - Google Patents

Methods for measuring biomarkers in gastrointestinal cancer

Info

Publication number
SG11201605259QA
SG11201605259QA SG11201605259QA SG11201605259QA SG11201605259QA SG 11201605259Q A SG11201605259Q A SG 11201605259QA SG 11201605259Q A SG11201605259Q A SG 11201605259QA SG 11201605259Q A SG11201605259Q A SG 11201605259QA SG 11201605259Q A SG11201605259Q A SG 11201605259QA
Authority
SG
Singapore
Prior art keywords
methods
gastrointestinal cancer
measuring biomarkers
biomarkers
measuring
Prior art date
Application number
SG11201605259QA
Other languages
English (en)
Inventor
Boon Ooi Patrick Tan
Masafumi Muratani
Aditi Qamra
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Priority to SG11201605259QA priority Critical patent/SG11201605259QA/en
Publication of SG11201605259QA publication Critical patent/SG11201605259QA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG11201605259QA 2013-12-30 2014-12-30 Methods for measuring biomarkers in gastrointestinal cancer SG11201605259QA (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG11201605259QA SG11201605259QA (en) 2013-12-30 2014-12-30 Methods for measuring biomarkers in gastrointestinal cancer

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG2013096896 2013-12-30
PCT/SG2014/000625 WO2015102536A1 (en) 2013-12-30 2014-12-30 Methods for measuring biomarkers in gastrointestinal cancer
SG11201605259QA SG11201605259QA (en) 2013-12-30 2014-12-30 Methods for measuring biomarkers in gastrointestinal cancer

Publications (1)

Publication Number Publication Date
SG11201605259QA true SG11201605259QA (en) 2016-07-28

Family

ID=53493765

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201605259QA SG11201605259QA (en) 2013-12-30 2014-12-30 Methods for measuring biomarkers in gastrointestinal cancer

Country Status (6)

Country Link
US (1) US20160355886A1 (zh)
EP (1) EP3090065B1 (zh)
JP (1) JP6553085B2 (zh)
CN (1) CN106103739B (zh)
SG (1) SG11201605259QA (zh)
WO (1) WO2015102536A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017142485A1 (en) * 2016-02-16 2017-08-24 Agency For Science, Technology And Research Cancer epigenetic profiling
SG11201806946VA (en) * 2016-02-16 2018-09-27 Agency Science Tech & Res Epigenomic profiling reveals the somatic promoter landscape of primary gastric adenocarcinoma
CN109862903B (zh) 2016-04-28 2023-04-14 新加坡国立大学 治疗性sall4肽
CN110691792A (zh) 2017-01-10 2020-01-14 朱诺治疗学股份有限公司 细胞疗法的表观遗传学分析及相关方法
CN108345741B (zh) * 2017-12-13 2021-07-09 湘潭大学 基于无网格rkpm各向异性材料二维热变形和热应力分析方法
JP2021526361A (ja) * 2018-05-17 2021-10-07 ソシエテ・デ・プロデュイ・ネスレ・エス・アー Nkx6.3を調節する方法
EP3899019A4 (en) * 2018-12-21 2022-10-05 Agency for Science, Technology and Research METHOD OF PREDICTING THE BENEFITS OF THERAPY BASED ON IMMUNE CHECKPOINT INHIBITION
JP2022523564A (ja) 2019-03-04 2022-04-25 アイオーカレンツ, インコーポレイテッド 機械学習を使用するデータ圧縮および通信
IT201900021327A1 (it) * 2019-11-15 2021-05-15 Fond Del Piemonte Per Loncologia Sequenze di oligonucleotidi antisenso per silenziare il trascritto L1-MET umano nei tumori.
WO2024096536A1 (ko) * 2022-10-31 2024-05-10 주식회사 지씨지놈 폐암 진단용 dna 메틸화 마커 및 이의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
WO2008083251A2 (en) * 2006-12-27 2008-07-10 Usc Stevens - University Of Southern California Dna methylation markers based on epigenetic stem cell signatures in cancer
WO2008103763A2 (en) * 2007-02-20 2008-08-28 Sequenom, Inc. Methods and compositions for cancer diagnosis and treatment based on nucleic acid methylation
EP2390371A1 (en) * 2007-11-30 2011-11-30 Genomictree, Inc. Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
JP2012524278A (ja) * 2009-04-14 2012-10-11 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア がんの臨床診断および予後診断のためのヒストン修飾パターン

Also Published As

Publication number Publication date
JP6553085B2 (ja) 2019-07-31
US20160355886A1 (en) 2016-12-08
WO2015102536A1 (en) 2015-07-09
EP3090065A4 (en) 2017-08-02
EP3090065B1 (en) 2019-12-11
CN106103739B (zh) 2019-12-06
CN106103739A (zh) 2016-11-09
JP2017506909A (ja) 2017-03-16
EP3090065A1 (en) 2016-11-09

Similar Documents

Publication Publication Date Title
HK1217219A1 (zh) 結直腸癌生物標誌物
HRP20181566T1 (hr) Biomarkeri raka i njihove uporabe
HK1210832A1 (zh) 利用生物標誌物進行癌症診斷
EP2825674A4 (en) BIOMARKER FOR THYROID CANCER
SG11201605259QA (en) Methods for measuring biomarkers in gastrointestinal cancer
EP2967479A4 (en) BIOPSY GUIDED BY TOMOSYNTHESIS IN A LAYERED POSITION
HK1206414A1 (zh) 對胃癌的生物標記物及其用途
SG11201510210XA (en) Methods for detecting prostate cancer
EP2931922A4 (en) PERSONALIZED BIOMARKERS FOR CANCER
IL233803A0 (en) Monocyte biomarkers for cancer detection
EP2947453A4 (en) BIOMOLEKÜLMESSVORRICHTUNG
ZA201506640B (en) Tunnel gage
HK1221503A1 (zh) 分析測試儀
GB201321474D0 (en) Novel biomarkers
GB201322800D0 (en) Prostate cancer biomarkers
HK1224010A1 (zh) 卵巢癌生物標誌物
GB201309426D0 (en) Biomarkers
IL244632A0 (en) Cancer biomarker and diagnostics
EP2948769A4 (en) BLOOD PLATE BIOMARKERS IN CANCER DIAGNOSIS
GB201316526D0 (en) Biomarkers
GB201308077D0 (en) Biomarkers
GB2534318B (en) Biomolecule measuring device
GB201316524D0 (en) Biomarkers
GB201312638D0 (en) Biomarkers
GB201306339D0 (en) Biomarkers for prognosis